GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » NetraMark Holdings Inc (XCNQ:AIAI) » Definitions » Earnings Yield (Joel Greenblatt) %

NetraMark Holdings (XCNQ:AIAI) Earnings Yield (Joel Greenblatt) % : -10.82% (As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is NetraMark Holdings Earnings Yield (Joel Greenblatt) %?

NetraMark Holdings's Enterprise Value for the quarter that ended in Dec. 2023 was C$22.40 Mil. NetraMark Holdings's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was C$-2.43 Mil. NetraMark Holdings's Earnings Yield (Joel Greenblatt) for the quarter that ended in Dec. 2023 was -10.82%.

The historical rank and industry rank for NetraMark Holdings's Earnings Yield (Joel Greenblatt) % or its related term are showing as below:

XCNQ:AIAI' s Earnings Yield (Joel Greenblatt) % Range Over the Past 10 Years
Min: -135.03   Med: -44.14   Max: -14.14
Current: -14.14

During the past 4 years, the highest Earnings Yield (Joel Greenblatt) of NetraMark Holdings was -14.14%. The lowest was -135.03%. And the median was -44.14%.

XCNQ:AIAI's Earnings Yield (Joel Greenblatt) % is ranked worse than
80.21% of 682 companies
in the Healthcare Providers & Services industry
Industry Median: 2.62 vs XCNQ:AIAI: -14.14

Joel Greenblatt's definition of earnings yield has the same problems the regular earnings yield does. It does not consider the growth of the company. It only looks at one-year's business operation. For cyclical companies, the earnings yield is usually highest at the peak of the business cycle. But these earnings are rarely sustainable.

A better indicator of the attractiveness of an investment which takes growth into account is the Forward Rate of Return (Yacktman) %. NetraMark Holdings's Forward Rate of Return (Yacktman) % for the quarter that ended in Dec. 2023 was 0.00%. The Forward Rate of Return uses the normalized Free Cash Flow of the past seven years, and considers growth. The forward rate of return can be thought of as the return that investors buying the stock today can expect from it in the future.


NetraMark Holdings Earnings Yield (Joel Greenblatt) % Historical Data

The historical data trend for NetraMark Holdings's Earnings Yield (Joel Greenblatt) % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NetraMark Holdings Earnings Yield (Joel Greenblatt) % Chart

NetraMark Holdings Annual Data
Trend Sep20 Sep21 Sep22 Sep23
Earnings Yield (Joel Greenblatt) %
- -10.08 -62.11 -25.38

NetraMark Holdings Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Sep23 Dec23
Earnings Yield (Joel Greenblatt) % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -62.11 -90.91 -29.50 -25.38 -10.82

Competitive Comparison of NetraMark Holdings's Earnings Yield (Joel Greenblatt) %

For the Health Information Services subindustry, NetraMark Holdings's Earnings Yield (Joel Greenblatt) %, along with its competitors' market caps and Earnings Yield (Joel Greenblatt) % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


NetraMark Holdings's Earnings Yield (Joel Greenblatt) % Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, NetraMark Holdings's Earnings Yield (Joel Greenblatt) % distribution charts can be found below:

* The bar in red indicates where NetraMark Holdings's Earnings Yield (Joel Greenblatt) % falls into.



NetraMark Holdings Earnings Yield (Joel Greenblatt) % Calculation

In his book, The Little That Beat the Market, hedge fund manager Joel Greenblatt defines Earnings Yield as operating income divided by enterprise value.

NetraMark Holdingss Earnings Yield (Joel Greenblatt) for the fiscal year that ended in Sep. 2023 is calculated as

Earnings Yield (Joel Greenblatt)=EBIT/Enterprise Value
=-5.969/23.4885915
=-25.41 %

NetraMark Holdings's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-2.43 Mil.



NetraMark Holdings  (XCNQ:AIAI) Earnings Yield (Joel Greenblatt) % Explanation

Joel Greenblatt defines the earnings yield using the above equation because it more accurately reflects the company's profitability relative to its stock price. Items like interest payment and tax etc. are not directly related to the company's operational profitability.

Enterprise Value instead of market cap (share price) is used in the calculation because it is the real price stock and bond investors together pay for the company.


Be Aware

Joel Greenblatt's definition of earnings yield has the same problems the regular earnings yield does. It does not consider the growth of the company. It only looks at one-year's business operation. For cyclical companies, the earnings yield is usually highest at the peak of the business cycle. But these earnings are rarely sustainable.

Forward Rate of Return (Yacktman) % based on Don Yacktman's definition is a better measure of the expected rate of return for a stock.


NetraMark Holdings Earnings Yield (Joel Greenblatt) % Related Terms

Thank you for viewing the detailed overview of NetraMark Holdings's Earnings Yield (Joel Greenblatt) % provided by GuruFocus.com. Please click on the following links to see related term pages.


NetraMark Holdings (XCNQ:AIAI) Business Description

Traded in Other Exchanges
Address
1655 Dupont Street, Suite 101, Toronto, ON, CAN, M6P 3T1
NetraMark Holdings Inc is focused on the application of a totally unique Artificial Intelligence (AI) / Machine Learning (ML) solution targeted at the pharmaceutical industry in order to de-risk clinical trials. NetraMark has a proprietary technology that is capable of cutting through the combinatorial complexity that comes with dealing with heterogeneous patient populations to extract precisely defined personas of patients with respect to placebo and drug response, in addition to tolerability and adverse events. By using the client's own contemporaneous data, and having the capacity to learn from small data, the NetraAI tech extracts these personas to equip pharmaceutical companies with strategies to optimize their next trials for success.
Executives
Andrew Parks Director

NetraMark Holdings (XCNQ:AIAI) Headlines

No Headlines